DSpace@İnönü

Başlık için listeleme

Başlık için listeleme

Sırala: Sıra: Sonuçlar:

  • Effects of ınjectable platelet-rich fibrin in experimental periodontitis in rats 
    Aydinyurt, H.S.; Sancak, T.; Taskin, C.; Basbugan, Y.; Akinci, L. (2021)
    Injectable platelet-rich fibrin (i-PRF) is an effective biological material that positively contributes to angiogenesis, wound healing, inflammation, regeneration processes, etc. This research aimed to evaluate the effect ...
  • Effects of ıntracerebroventricular administration of salusin-beta on food ıntake, water consumptionand body weight in male rats 
    Demir, İlker; Tekin, Suat; Sandal, Süleyman (KARGER, ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, 2018)
  • Effects of α-tocopherol, β-carotene and ascorbyl palmitate on oxidative stability of butter oil triacylglycerols 
    Karabulut, I. (2010)
    Butter oil triacylglycerols (BO-TAGs), free of antioxidants, including β-carotene, were obtained via sequential treatments with activated carbon (AC) adsorption and alumina column chromatography. α-Tocopherol, β-carotene ...
  • Effects on Anxiety and Vital Signs of the Emotional Freedom Technique 
    Cici, R; Ozkan, M (2022)
    Context Patients hospitalized for surgical treatment for lumbar disc herniation (LDH) are adversely affected psychologically, with fury, anger, helplessness, anxiety, and depression being observed in patients. Anxiety in ...
  • Effects on Anxiety and Vital Signs of the Emotional Freedom Technique 
    Cici, R; Ozkan, M (2022)
    Context Patients hospitalized for surgical treatment for lumbar disc herniation (LDH) are adversely affected psychologically, with fury, anger, helplessness, anxiety, and depression being observed in patients. Anxiety in ...
  • Effects on Anxiety and Vital Signs of the Emotional Freedom Technique and Music Before Surgery for Lumbar Disc Hernia 
    Cici, R.; Özkan, M. (2022)
    Context • Patients hospitalized for surgical treatment for lumbar disc herniation (LDH) are adversely affected psychologically, with fury, anger, helplessness, anxiety, and depression being observed in patients. Anxiety ...
  • The efficacy and reliability of extracorporeal shockwave lithotripsy (eswl) nin pediatric urolithiasis: Our clinical experiences 
    Altıntaş, Ramazan; Taşdemir, Cemal; Oğuz, Fatih; Beytur, Ali; Çimen, Serhan; Güneş, Ali (Turgut Özal Tıp Merkezi Dergisi, 2014)
    Öz:Amaç: Beden dışı şok dalgaları ile taş kırma (ESWL) tedavisi, erişkin hastalarda olduğu gibi çocuk yaş grubunda da son yıllarda sıkça uygulanan bir tedavi yöntemidir. Bu çalışmada kliniğimizde böbrek ve üreter taşları ...
  • Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine 
    Tanriover, MD; Doganay, HL; Akova, M; Guner, HR; Azap, A; Akhan, S; Kose, S; Erdinc, FS; Akalin, EH; Tabak, OF; Pullukcu, H; Batum, O; Yavuz, SS; Turhan, O; Yildirmak, MT; Koksal, I; Tasova, Y; Korten, V; Yilmaz, G; Celen, MK; Altin, S; Celik, I; Bayindir, Y; Karaoglan, I; Yilmaz, A; Ozkul, A; Gur, H; Unal, S (2021)
    Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral ...
  • Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine 
    Tanriover, MD; Doganay, HL; Akova, M; Guner, HR; Azap, A; Akhan, S; Kose, S; Erdinc, FS; Akalin, EH; Tabak, OF; Pullukcu, H; Batum, O; Yavuz, SS; Turhan, O; Yildirmak, MT; Koksal, I; Tasova, Y; Korten, V; Yilmaz, G; Celen, MK; Altin, S; Celik, I; Bayindir, Y; Karaoglan, I; Yilmaz, A; Ozkul, A; Gur, H; Unal, S (2021)
    Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral ...
  • Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey 
    Tanriover, M.D.; Doğanay, H.L.; Akova, M.; Güner, H.R.; Azap, A.; Akhan, S.; Köse; Erdinç, F.Ş.; Akalın, E.H.; Tabak, Ö.F.; Pullukçu, H.; Batum, Ö.; Şimşek Yavuz, S.; Turhan, Ö.; Yıldırmak, M.T.; Köksal, İ.; Taşova, Y.; Korten, V.; Yılmaz, G.; Çelen, M.K.; Altın, S.; Çelik, İ.; Bayındır, Y.; Karaoğlan, İ.; Yılmaz, A.; Özkul, A.; Gür, H.; Unal, S.; Kayaaslan, B.; Hasanoğlu, İ.; Dalkıran, A.; Aydos, Ö.; Çınar, G.; Akdemir-Kalkan, İ.; İnkaya, A.Ç.; Aydin, M.; Çakir, H.; Yıldız, J.; Kocabıyık, Ö.; Arslan, S.; Nallı, B.; Demir, Ö.; Singil, S.; Ataman-Hatipoğlu, Ç.; Tuncer-Ertem, G.; Kınıklı, S.; Önal, U.; Mete, B.; Dalgan, G.; Taşbakan, M.; Yamazhan, T.; Kömürcüoğlu, B.; Yalnız, E.; Benli, A.; Keskin-Sarıtaş, Ç.; Ertosun, M.G.; Özkan, Ö.; Emre, S.; Arıca, S.; Kuşçu, F.; Candevir, A.; Ertürk-Şengel, B.; Ayvaz, F.; Aksoy, F.; Mermutluoğlu, Ç.; Demir, Y.; Günlüoğlu, G.; Tural-Önür, S.; Kılıç-Toker, A.; Eren, E.; Otlu, B.; Mete, A.Ö.; Koçak, K.; Ateş, H.; Koca-Kalkan, İ.; Aksu, K.; CoronaVac Study Group (2021)
    Background: CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral ...
  • Efficacy and Safety of flecainide p.os. in cardioversion of recent-onset atrial fibrillation 
    Vogiatzis, Ioannis; Sdogkos, Evangelos; Koutsampasopoulos, Konstantinos (2021)
    Aim: The aim of the study was to identify the level of safety and the efficacy of flecainide per o.s. in patients with recent-onset (<48 hours) AF. The management of patients with recent-onset Atrial Fibrillation (AF) ...
  • Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic 
    Tombak, A; Tanrikulu, FP; Durusoy, SS; Dincyurek, HD; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocamaz, V; Gunes, AK; Sahip, B; Ertop, S; Akay, OM; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Gurkan, E; Cekdemir, D; Ferhanoglu, B (2021)
    Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...
  • Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic 
    Tombak, A; Tanrikulu, FP; Durusoy, SS; Dincyurek, HD; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocamaz, V; Gunes, AK; Sahip, B; Ertop, S; Akay, OM; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Gurkan, E; Cekdemir, D; Ferhanoglu, B (2021)
    Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...
  • Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data 
    Tombak, A.; Tanrıkulu, F.P.; Durusoy, S.S.; Dinçyürek, H.D.; Kaya, E.; Ümit, E.G.; Yavaşoğlu, İ.; Mehtap, Ö.; Deveci, B.; Özcan, M.A.; Terzi, H.; Okay, M.; Sayınalp, N.; Yılmaz, M.; Okan, V.; Kızıklı, A.; Özcan, Ö.; Çetin, G.; Demircioğlu, S.; Aydoğdu, İ.; Saydam, G.; Davulcu, E.A.; İlhan, G.; Uçar, M.A.; Özet, G.; Akpınar, S.; Turgut, B.; Berber, İ.; Kurtoğlu, E.; Sönmez, M.; Batur, D.S.; Yıldırım, R.; Özkocamaz, V.; Güneş, A.K.; Sahip, B.; Ertop, Ş.; Akay, O.M.; Baştürk, A.; Doğu, M.H.; Akdeniz, A.; Ünal, A.; Seyhanlı, A.; Gürkan, E.; Çekdemir, D.; Ferhanoğlu, B. (2021)
    Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...
  • Efficacy and Safety of Ibrutinib Use in Patients with Chronic 
    Tombak, A; Tanrikulu, FP; Durusoy, SS; Gurkan, E; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocaman, V; Gunes, AK; Sahip, B; Ertop, S; Akay, M; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Ferhanoglu, B (2019)
  • Efficacy and safety of ruxolitinib in patients with myelofibrosis: a 
    Soyer, N; Ali, R; Turgut, M; Haznedaroglu, IC; Yilmaz, F; Aydogdu, I; Pir, A; Karakus, V; Ozgur, G; Kis, C; Ceran, F; Ilhan, G; Ozkan, M; Aslaner, M; Ince, I; Yavasoglu, I; Gediz, F; Sonmez, M; Guvenc, B; Ozet, G; Kaya, E; Vural, F; Sahin, F; Tobu, M; Durusoy, R; Saydam, G (2021)
    Background/aim: The aim of this study is to assess the efficacy and safety of ruxolitinib in patients with myelofibrosis. Materials and methods: From 15 centers, 176 patients (53.4% male, 46.6% female) were retrospectively ...
  • Efficacy and safety of ruxolitinib in patients with myelofibrosis: A retrospective and multicenter experience in turkey 
    Soyer, N.; Ali, R.; Turgut, M.; Haznedaroğlu, İ.C.; Yilmaz, F.; Aydoğdu, İ.; Pir, A.; Karakuş, V.; Özgür, G.; Kiş, C.; Ceran, F.; Ilhan, G.; Özkan, M.; Aslaner, M.; Ince, İ.; Yavaşoğlu, İ.; Gediz, F.; Sönmez, M.; Güvenç, B.; Özet, G.; Kaya, E.; Vural, F.; Şahin, F.; Töbü, M.; Durusoy, R.; Saydam, G. (2021)
    Background/aim: The aim of this study is to assess the efficacy and safety of ruxolitinib in patients with myelofibrosis. Materials and methods: From 15 centers, 176 patients (53.4% male, 46.6% female) were retrospectively ...
  • EFFICACY AND SAFETY OF RUXOLITINIB IN TURKISH PATIENTS WITH CHRONIC 
    Soyer, N; Turgut, M; Haznedaroglu, I; Yilmaz, F; Aydogdu, I; Pir, A; Karakus, V; Ozgur, G; Kis, C; Ceran, F; Ilhan, G; Ozkan, M; Arslaner, M; Ince, I; Yavasoglu, I (2017)
  • "Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience" 
    Sarici, Ahmet; Erkurt, Mehmet Ali; Bahcecioglu, Omer Faruk; Tanriverdi, Lokman Hekim; Berber, İlhami; Kaya, Emin; Biçim, Soykan; Gok, Selim; Özgül, Mustafa; Kuku, İrfan (2021)
    Abstract:Aim: There is no standard treatment for corticosteroid refractory acute and chronic graft versus host disease (GVHD). Ruxolitinib and extracorporeal phopheresis (ECP) are promising treatment options in GVHD. In ...
  • EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B 
    Adanir, H; Etik, DO; Yildirim, AE; Mehdiyev, S; Yapali, S; Cosar, AM; Ari, D; Gokcan, H; Teker, T; Kiyici, M; Balaban, YH; Alkim, H; Ucbilek, E; Unsal, Y; Harputluoglu, M; Vatansever, S; Demir, M; Guzelbulut, F; Gunduz, F; Boyacioglu, S; Bilgic, Y; Ekmen, N; Arslan, M; Simsek, H; Akdogan, M; Dincer, D; Tozun, N; Idilman, R (2021)